Genome Medical Overview
- Founded
- 2016
- Status
- Private
- Employees
- 113
- Latest Deal Type
- Series C
- Latest Deal Amount
- $60M
- Investors
- 21
Genome Medical General Information
Description
Operator of a cloud-based genomic care delivery platform intended to bridge the gap between advancing genome technology and current medical practice. The company's platform connects individuals and health care providers to genetic experts, providing a genetic assessment to individuals regarding the benefits of testing and thereafter creating a personalized clinical action plan to incorporate test results for precision health care, enabling patients to make informed treatment decisions at low costs and medical practitioners to accelerate disease diagnosis.
Contact Information
Website
www.genomemedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Practice Management (Healthcare)
Other Healthcare Technology Systems
Managed Care
Primary Office
- 701 Gateway Boulevard
- Suite 380
- San Francisco, CA 94080
- United States
+1 (877) 000-0000
Genome Medical Timeline
Genome Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 25-Aug-2021 | $60M | 00000 | 00000 | Completed | Generating Revenue |
| 6. Secondary Transaction - Private | 0000 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 23-Jul-2020 | 0000 | 0000 | 0000 | Completed | Generating Revenue |
| 4. Accelerator/Incubator | 01-Oct-2018 | 0000 | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A1) | 22-Dec-2017 | 0000 | 0000 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 12-Apr-2017 | $10M | $12M | 0000 | Completed | Generating Revenue |
| 1. Seed Round | 01-Nov-2016 | $2M | $2M | 000 | Completed | Startup |
Genome Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 00,000,000 | 00.000000 | 00.0 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Seed | 4,251,063 | $0.000100 | $0.03 | $0.53 | $0.53 | 1x | $0.53 | 3.09% |
| Series AA | 12,926,897 | $0.000100 | $0.1 | $1.67 | $1.67 | 1x | $1.67 | 9.4% |
Genome Medical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a cloud-based genomic care delivery platform intended to bridge the gap between advancing genome technology
Clinics/Outpatient Services
San Francisco, CA
113
As of 2021
00000
0000
0000-00-00
00000000000
00000
00000000
x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
00000 0000000000 00000000
Saint Petersburg, FL
000
As of 0000
000.00
0000000000 0
000.00
00000
do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
00000 0000000000 0000000000 0000000
Paris, France
000
As of 0000
00000
0.000
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialGenome Medical Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InformedDNA | Venture Capital-Backed | Saint Petersburg, FL | 000 | 000.00 | 0000000000 0 | 000.00 |
| 00000 | Venture Capital-Backed | Paris, France | 000 | 00000 | 00000000000 | 00000 |
| 000000000 00000000 | Formerly VC-backed | Espoo, Finland | 000 | 000.00 | 000000&0 | 000.00 |
| 0000000 000000 | Venture Capital-Backed | San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 00000000 | Formerly VC-backed | San Diego, CA | 00 | 000.00 | 00000000 |
Genome Medical Executive Team (18)
Genome Medical Board Members (15)
| Name | Representing | Role | Since |
|---|---|---|---|
| Amy Raimundo | Kaiser Permanente Ventures | Board Observer | 000 0000 |
| Anthony Philippakis Ph.D | GV | Board Observer | 000 0000 |
| Eli Casdin | Casdin Capital | Board Member | 000 0000 |
| Jessica Zeaske Ph.D | Echo Health Ventures | Board Member | 000 0000 |
| Jill Davies | Genome Medical | Board Member & Chief Customer Officer | 000 0000 |
Genome Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGenome Medical Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Amgen Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| GV | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Alumni Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Avestria Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Casdin Capital | Hedge Fund | Minority | 000 0000 | 000000 0 |
Genome Medical Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000000 | 30-Aug-2021 | 0000000000 | Other Healthcare Services | 0000 0000 |
Genome Medical Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000000 | Other Healthcare Services | Minneapolis, MN | 0000 |